Back
Pacific Biosciences of California Quote, Financials, Valuation and Earnings

Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
55
PACB
Pacific Biosciences of California
Last Price:
11.79
Seasonality Move:
-17.71%
7 Day Trial
ALL ACCESS PASS
$
7

New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register HerePacific Biosciences of California Price Quote
$11.79
-0.20 (-1.67%)
(Updated: January 27, 2023 at 6:50 PM ET)
Pacific Biosciences of California Key Stats
Buy
55
Pacific Biosciences of California (PACB)
is a Buy
Day range:
$11.15 - $12.02
52-week range:
$3.85 - $14.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.56
P/B ratio:
4.33%
Volume:
5.3M
Avg. volume:
4.3M
1-year change:
22.47%
Market cap:
$2.7B
Revenue:
$130.5M
EPS:
$-1.34
How Much Does Pacific Biosciences of California Make?
-
How Much Are Pacific Biosciences of California's Sales Annually?
PACB Revenues are $130.5M -
How Much Profit Does Pacific Biosciences of California's Make A Year?
PACB net income is -$181.2M
Is Pacific Biosciences of California Growing As A Company?
-
What Is Pacific Biosciences of California's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.07% -
What Is Pacific Biosciences of California's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Pacific Biosciences of California Stock Price Performance
-
Did Pacific Biosciences of California Stock Go Up Last Month?
Pacific Biosciences of California share price went up by 41.23% last month -
Did PACB's Share Price Rise Over The Last Year?
PACB share price rose by 22.47% over the past 1 year
What Is Pacific Biosciences of California 52-Week High & Low?
-
What Is Pacific Biosciences of California’s 52-Week High Share Price?
Pacific Biosciences of California has traded as high as $14.20 over the past 52 weeks -
What Is Pacific Biosciences of California’s 52-Week Low Share Price?
Pacific Biosciences of California has traded as low as $3.85 over the past 52 weeks
Pacific Biosciences of California Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Pacific Biosciences of California?
-
How Much Debt Does Pacific Biosciences of California Have?
Total long term debt quarterly is $896.5M -
How Much Cash Does Pacific Biosciences of California Have?
Cash and short term investments quarterly total is $834.3M -
What Is Pacific Biosciences of California’s Book Value Per Share?
Book value per share is 2.77
Is Pacific Biosciences of California Cash Flow Positive?
-
What Is PACB Cash Flow From Operations?
Cash flow from operations (TTM) is -$234.4M -
What Is Pacific Biosciences of California’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.1M -
What Is Pacific Biosciences of California’s Cash Flow From Investing?
Cash flow from investing (TTM) is $101.4M
Pacific Biosciences of California Return On Invested Capital
-
Is Management Doing A Good Job?
PACB return on invested capital is -18.34% -
What Is Pacific Biosciences of California Return On Assets?
ROA measures how assets are converting to revenues and is -15.47% -
What Is PACB Return On Equity?
ROE is a measure of profitability and is -40.71%
Pacific Biosciences of California Earnings Date & Stock Price
-
What Is Pacific Biosciences of California's Stock Price Today?
A single share of PACB can be purchased today for 11.99 -
What Is Pacific Biosciences of California’s Stock Symbol?
Pacific Biosciences of California trades on the nasdaq under the ticker symbol: PACB -
When Is Pacific Biosciences of California’s Next Earnings Date?
The next quarterly earnings date for Pacific Biosciences of California is scheduled on February 15, 2023 -
When Is PACB's next ex-dividend date?
Pacific Biosciences of California's next ex-dividend date is January 28, 2023 -
How To Buy Pacific Biosciences of California Stock?
You can buy Pacific Biosciences of California shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Pacific Biosciences of California Competitors
-
Who Are Pacific Biosciences of California's Competitors?
Below is a list of companies who compete with Pacific Biosciences of California or are related in some way:
Pacific Biosciences of California Dividend Yield
Data Unavailable
Pacific Biosciences of California Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 3.03% |
Revenue: | -7.38% | -8.73% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 12.14 |
Upside from Last Price: | 1.27% |